Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05966883

SpermQT Prospective Observational Trial

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Inherent Biosciences · Industry
Sex
All
Age
18 Years – 45 Years
Healthy volunteers

Summary

The goal of the study is to validate the ability of the Epigenetic Sperm Quality Test (SpermQT) to assess a man's sperm quality and corresponding success of infertility treatments.

Detailed description

This prospective study will consist of analyzing a man's semen sample to determine the patient's SpermQT score and following the success of each fertility treatment to produce a pregnancy and live birth. Physicians and patients will be blinded to SpermQT results.

Conditions

Timeline

Start date
2023-01-01
Primary completion
2026-04-15
Completion
2026-09-30
First posted
2023-08-01
Last updated
2026-03-12

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05966883. Inclusion in this directory is not an endorsement.